BIOMAT Database Logo BIOMAT Database Logo

[Therapeutic results of dysentery with aminodeoxykanamycin (Kanendomycin 'Meiji')]. 1970

D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito

UI MeSH Term Description Entries
D008034 Lincomycin An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. Lincolnensin,Lincomycin, (2S-cis)-Isomer,Epilincomycin,Lincocin,Lincomycin A,Lincomycin Hydrochloride,Lincomycin Monohydrochloride,Lincomycin Monohydrochloride, (2S-cis)-Isomer,Lincomycin Monohydrochloride, (L-threo)-Isomer,Lincomycin Monohydrochloride, Hemihydrate,Lincomycin, (L-threo)-Isomer,Hemihydrate Lincomycin Monohydrochloride
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003510 Cyclohexanes Six-carbon alicyclic hydrocarbons.
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004405 Dysentery, Bacillary DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest). Shigellosis,Dysentery, Shiga bacillus,Dysentery, Shigella boydii,Dysentery, Shigella dysenteriae,Dysentery, Shigella dysenteriae type 1,Dysentery, Shigella flexneri,Dysentery, Shigella sonnei,Shigella Dysentery,Shigella Infection,Bacillary Dysentery,Dysenteries, Shigella,Dysenteries, Shigella boydii,Dysenteries, Shigella dysenteriae,Dysenteries, Shigella flexneri,Dysenteries, Shigella sonnei,Dysentery, Shigella,Infection, Shigella,Infections, Shigella,Shiga bacillus Dysentery,Shigella Dysenteries,Shigella Infections,Shigella boydii Dysenteries,Shigella boydii Dysentery,Shigella dysenteriae Dysenteries,Shigella dysenteriae Dysentery,Shigella flexneri Dysenteries,Shigella flexneri Dysentery,Shigella sonnei Dysenteries,Shigella sonnei Dysentery

Related Publications

D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Clinical experience with aminodeoxykanamycin (Kanendomycin 'Meiji') in the treatment of bacillary dysentery].
June 1970, The Japanese journal of antibiotics,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Sensitivity test of aminodeoxykanamycin (Kanendomycin 'Meiji') by a disc method].
June 1970, The Japanese journal of antibiotics,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Application of aminodeoxykanamycin (Kanendomycin 'Meiji') in the field of internal medicine].
August 1971, The Japanese journal of antibiotics,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Experimental studies and clinical experience with aminodeoxykanamycin (Kanendomycin 'Meiji') in bone and joint infections, especially in open injuries and postoperative infections].
December 1970, The Japanese journal of antibiotics,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Kanendomycin therapy in bacillary dysentery].
June 1970, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Therapeutic results of dysentery patients and carriers wth aminobenzyl penicillin (Viccillin Meiji), with special reference to the effect on resistant strains].
October 1965, The Journal of antibiotics. Ser. B,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Therapeutic results of bacillary dysentery with film-coated panfuran S].
June 1967, Nihon Densenbyo Gakkai zasshi,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Therapeutic results in an epidemic outbreak of dysentery].
January 1977, Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Bacteriologia, virusologia, parazitologia, epidemiologia,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Therapeutic results of Kanendomycin in infectious otorhinolaryngological diseases and its effect on the organ of hearing].
September 1969, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
D Naito, and M Kobayashi, and C Imai, and S Yamada, and H Ito
[Oral kanendomycin therapy in antibiotic-resistant bacillary dysentery and other acute febrile diarrheal diseases].
March 1970, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Copied contents to your clipboard!